Dupixent OverviewDupilumab is a monoclonal antibody designed for the treatment of atopic diseases such as eczema. Side effects include allergic reactions, cold sores, and inflammation of the cornea. It was developed by Regeneron Pharmaceuticals and Sanofi. The US Food and Drug Administration has designated dupilumab a “breakthrough therapy” which is designed to speed promising new drugs to market. It received FDA approval in 2017. As of 2017 it costs about 37,000 USD per year....
Read more Dupixent Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dupilumab
Recent Dupixent Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 150mg/ml
NDC Database Records for Dupixent: (1 result)Sorted by National Drug Code
- 0024-5914 Dupixent 300 mg/2ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC